BSL Raffles Medical
- 0.995
- -0.005-0.50%
Raffles Medical News
Raffles Medical Group Announces Board Changes
Raffles Medical Group's (SGX:BSL) Returns Have Hit A Wall
Raffles Medical Group Full Year 2023 Earnings: EPS Misses Expectations
Raffles Medical Group (SGX:BSL) Will Pay A Smaller Dividend Than Last Year
Union Steel Co-founder Ang Yew Chye Ups Stake
INSTITUTIONS continued to be net buyers of Singapore stocks over the four trading sessions through to Mar 27, with S$211 million of net institutional inflow, as 22 primary-listed companies conducted b
Raffles Medical Group Ltd (SGX:BSL) Shares Could Be 34% Below Their Intrinsic Value Estimate
Raffles Medical Chair Continues Purchases; Sam Goi Ups PSC Stake
Institutions were net buyers of Singapore stocks over the five trading sessions through to Mar 21, with S$257 million of net institutional inflow, as 23 primary-listed companies conducted buybacks wit
Loo Continues Raffles Medical Share Spree as Weekly Tally Climbs to 500,000 Units
Raffles Medical CEO Loo Acquires 100,000 Shares at $1.03 Each
Raffles Medical Executive Chair Continues Acquisitions, CDL Leads Buyback Consideration
GRAPHIC: HANNAH KWAHInstitutions were net sellers of Singapore stocks over the five trading sessions through to Mar 14, with S$156 million of net institutional outflow, as 24 primary-listed companies
An Intrinsic Calculation For Raffles Medical Group Ltd (SGX:BSL) Suggests It's 34% Undervalued
Key Insights Raffles Medical Group's estimated fair value is S$1.58 based on 2 Stage Free Cash Flow to Equity Raffles Medical Group is estimated to be 34% undervalued based on current share price of
Business Activity Expands in Singapore's Private Sector in February as Demand Improves
Business activity in Singapore's private sector expanded in February, thanks to improving demand, driving a record rise in employment during the month, S&P Global reported Tuesday.
Executive Chairman & CEO of Raffles Medical Group Picks Up 1.7% More Stock
CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.16 From SG$1.20, Keeps at Buy
04:07 AM EST, 02/29/2024 (MT Newswires) -- CGS-CIMB Research Adjusts Raffles Medical Group's Price Target to SG$1.16 From SG$1.20, Keeps at Buy Price (SGD): S$1.02, Change: S$0.00, Percent Change: 0.0
Raffles Medical Group's Near-Term Earnings Prospects Seem Lackluster -- Market Talk
0722 GMT - Raffles Medical Group's near-term earnings prospects seem lackluster after posting worse-than-expected 2023 results, Phillip Securities Research analyst Paul Chew says in a commentary. The
Raffles Medical Group Target Price Lowered to S$0.96 From S$1.02 by Phillip Securities Research >BSL.SG
Raffles Medical Group Target Price Lowered to S$0.96 From S$1.02 by Phillip Securities Research >BSL.SG
Analysts Offer Insights on Healthcare Companies: Raffles Medical Group (OtherRAFLF), Agilent (A) and Karuna Therapeutics (KRTX)
Raffles Medical's Earnings Growth Prospects Face Headwinds -- Market Talk
0617 GMT - Raffles Medical Group's earnings growth prospects still face risks following its weak 2H results, RHB Research analyst Shekhar Jaiswal says in a research note as RHB lowers the stock's targ
Raffles Medical Target Price Cut to S$1.15 From S$1.30 by Maybank >BSL.SG
Raffles Medical Target Price Cut to S$1.15 From S$1.30 by Maybank >BSL.SG
Raffles Medical's Attributable Profit in H2 2023 Plunges 64%; Shares Down 4%
Raffles Medical Group's (SGX:BSL) attributable profit for the second half of 2023 plunged nearly 64% to SG$30.3 million, compared with SG$83.7 million in the year ago period. Earnings per share also n
Analysis
Price Target
No Data
